Pharmaceutical Technology12 小时
OVX-033 by Osivax for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
OVX-033 is under clinical development by Osivax and currently in Phase I for Coronavirus Disease 2019 (COVID-19).
Businessworld6 天
pakistan vs bangladesh t20
INR:0084. pakistan vs bangladesh t20 Zhimeng Pharmaceuticals' anti-HBV nucleocapsid inhibitor ZM-H1505R was approved for clinical trials Big news for c ...
Pharmaceutical Technology6 天
OVX-836 by Osivax for Unspecified Influenza Virus Infections: Likelihood of Approval
OVX-836 is under clinical development by Osivax and currently in Phase II for Unspecified Influenza Virus Infections.